// Add the new slick-theme.css if you want the default styling

ENDURING

SOLUTIONS.

enhance quality-of-life

Neuroview Technology is a data driven technology platform and medical device company focused on neurology outcomes. Our vision is to provide enduring solutions that enhance quality-of-life, improve clinical management and reduce cost of patient care.

OUR TECHNOLOGY

REAL TIME DATA of the patient’s Neurological state with EEG.

Data is downloaded to patient’s SMART PHONE

CLOUD provides bidirectional information between the patient and care team.

DATA analytics provided for efficient clinician review

NEUROVIEW TECHNOLOGY'S breakthrough device is a small implantable subcutaneous long-term Brain monitor using EEG.

There are no long-term electroencephalography (EEG) monitor devices approved by the FDA. All EEG studies even if intensive are limited to no more than a few days providing very little information. However, all brain disorders are dynamic in nature changing over time. EEG has been in clinical use for many decades and has been utilized in vascular disease, Parkinson’s, psychiatric disorders, and mainly epilepsy.



Epilepsy affects almost 4 million adults and children in United States with up to 30% who do not effectively respond to medical therapy. To date, no reliable objective biometric measure for epilepsy and seizures exists. Physicians rely on subjective seizure reporting by patients and families which is 40-50% accurate. NEUROVIEW’S novel technology accurately identifies unrecognized seizures, prevents false characterization of events, and provides information to optimize management. Under treated or untreated seizures resulting from lack of accurate seizure recognition is associated with a poor quality of life, increases the risk of accidents and sudden death, and greatly contributes to the already high cost of epilepsy. This technology is the first long-term, minimally invasive device for EEG monitoring.



Data-driven decision-making (DDDM): data science, data analysis and intelligent programming are essential to achieve success in healthcare by democratizing and personalizing healthcare. Employing AI/ML/DDN to analyze long-term EEG data will create a comprehensive knowledge platform that is updated continuously with ongoing information and from other separate knowledge domains for personalized and group utilization by all stake holders. Improving outcomes, reducing costs, reducing time to optimum treatments, improving diagnostics, predicting outcomes, etc., is some of the anticipated personalized care that AI will bring to brain disorders.

ABOUT NEUROVIEW TECHNOLOGY.

After 30 years of treating patients with epilepsy including those undergoing epilepsy surgery, Neuroview Technology co-founders have designed this device to be easily implantable with a 15 minute minimally invasive same day surgery procedure under local anesthesia. The EEG data which it records is delivered to the cloud via smart device technology. Analytics and relevant information is available to the patient and physician 24 hours a day. This novel technology truly represents a paradigm shift in brain monitoring and the treatment of epilepsy and other neurologic disorders.

THE NEUROVIEW TEAM

Founders

RUBEN KUZNIECKY, MD.

Learn More

Werner Doyle, MD.

Learn More

Steven Pacia, MD

Learn More

Daniel Friedman, MD

Learn More

Chief Executive Officer

JAMES KARWEL

Learn More

Board of Directors

Louis Rauchenberger

Board Member

Learn More

JAMES KARWEL

Learn More

RUBEN KUZNIECKY, MD.

Learn More

Werner Doyle, MD.

Learn More

Steven Pacia, MD

Learn More

Daniel Friedman, MD

Learn More

CTO

Barbara Gibb

Learn More

Advisory Committee

Gil Breiman

Legal Counsel

Learn More

Ben Pless

Consultant

Learn More

John Edge

Advisor

Learn More

NEWS.

CONTACT US.

If you would like to learn more about Neuroview Technology, have a specific question, or would like to get in touch directly, please fill out the form below.

I am:

Healthcare professional Investor A Patient Other

Name:

E-mail:

Message: